| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Internal Medicine [A. W., M. F., G. D.], Physiology, and Biophysics [A. Y.] and The Flow Cytometry Facility [J. F.], University of Iowa, Iowa City, Iowa 52242
Terminal cell differentiation of HL-60 promyelocytic leukemia cells results when they are continuously exposed to retinoic acid. This process involves an intermediate regulatory state, the precommitment memory state, which occurs before onset of differentiation or growth arrest in G0. The cellular processes occurring prior to onset of terminal differentiation can be resolved into early events anteceding development of the precommitment memory state and late events subsequent to it. While it has been suggested that retinoic acid induced early events regulate G1/n specific growth arrest associated with terminal differentiation, the significance of induced late events is not known. Exploiting the capability of HL-60 cells to undergo either myeloid or monocytic differentiation in response to different inducers, the present studies examine the response of HL-60 cells to the sequential application of myeloid and monocytic inducers prior to onset of terminal differentiation. The results indicate that the precommitment state induced by retinoic acid is not differentiation lineage specific. Sequential application first of retinoic acid, a myeloid inducer, and then of 1,25-dihydroxyvitamin D3, a monocytic inducer, and vice versa, show that cellular choice of a specific differentiation lineage is regulated by late inducer driven events. The data support a two-step model for induction of terminal differentiation where early events anteceding precommitment regulate growth arrest and late events subsequent to precommitment regulate choice of a specific differentiation lineage. The results are of potential significance to the use of differentiation-inducing agents in chemotherapy. The potential toxicity of prolonged exposure to a single inducer might thus be mitigated by sequential brief exposures to different inducers.
1 Supported in part by grants from the USPHS (NIH).
2 To whom requests for reprints should be addressed.
Received 6/ 9/86. Revised 9/ 9/86. Accepted 9/11/86.
This article has been cited by other articles:
![]() |
G. Reiterer and A. Yen Platelet-Derived Growth Factor Receptor Regulates Myeloid and Monocytic Differentiation of HL-60 Cells Cancer Res., August 15, 2007; 67(16): 7765 - 7772. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Balint, A. Szanto, A. Madi, U.-M. Bauer, P. Gabor, S. Benko, L. G. Puskas, P. J. A. Davies, and L. Nagy Arginine Methylation Provides Epigenetic Transcription Memory for Retinoid-Induced Differentiation in Myeloid Cells Mol. Cell. Biol., July 1, 2005; 25(13): 5648 - 5663. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yen, R. Fenning, R. Chandraratna, P. Walker, and S. Varvayanis A Retinoic Acid Receptor {beta}/{gamma}-Selective Prodrug (tazarotene) Plus a Retinoid X Receptor Ligand Induces Extracellular Signal-Regulated Kinase Activation, Retinoblastoma Hypophosphorylation, G0 Arrest, and Cell Differentiation Mol. Pharmacol., December 1, 2004; 66(6): 1727 - 1737. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang and A. Yen A Novel Retinoic Acid-Responsive Element Regulates Retinoic Acid-Induced BLR1 Expression Mol. Cell. Biol., March 15, 2004; 24(6): 2423 - 2443. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wightman, M. S. Roberson, T. J. Lamkin, S. Varvayanis, and A. Yen Retinoic Acid-induced Growth Arrest and Differentiation: Retinoic Acid Up-Regulates CD32 (Fc{gamma}RII) Expression, the Ectopic Expression of Which Retards the Cell Cycle Mol. Cancer Ther., May 1, 2002; 1(7): 493 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yen, L. Placanica, S. Bloom, and S. Varvayanis Polyomavirus Small t Antigen Prevents Retinoic Acid-Induced Retinoblastoma Protein Hypophosphorylation and Redirects Retinoic Acid-Induced G0 Arrest and Differentiation to Apoptosis J. Virol., June 1, 2001; 75(11): 5302 - 5314. [Abstract] [Full Text] |
||||
![]() |
R. Shaknovich, P. L. Yeyati, S. Ivins, A. Melnick, C. Lempert, S. Waxman, A. Zelent, and J. D. Licht The Promyelocytic Leukemia Zinc Finger Protein Affects Myeloid Cell Growth, Differentiation, and Apoptosis Mol. Cell. Biol., September 1, 1998; 18(9): 5533 - 5545. [Abstract] [Full Text] |
||||
![]() |
C. Asiedu, J. Biggs, and A. S. Kraft Complex Regulation of CDK2 During Phorbol Ester-Induced Hematopoietic Differentiation Blood, November 1, 1997; 90(9): 3430 - 3437. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Visnjic, D Batinic, and H Banfic Arachidonic acid mediates interferon-gamma-induced sphingomyelin hydrolysis and monocytic marker expression in HL-60 cell line Blood, January 1, 1997; 89(1): 81 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Biggs, J. E. Kudlow, and A. S. Kraft The Role of the Transcription Factor Sp1 in Regulating the Expression of the WAF1/CIP1 Gene in U937 Leukemic Cells J. Biol. Chem., January 12, 1996; 271(2): 901 - 906. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |